GE HealthCare Technologies Inc. $GEHC Shares Bought by Strs Ohio

Strs Ohio lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 407,945 shares of the company’s stock after purchasing an additional 22,005 shares during the quarter. Strs Ohio’s holdings in GE HealthCare Technologies were worth $30,637,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Allianz SE grew its stake in GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after buying an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after acquiring an additional 196 shares during the period. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the third quarter worth about $26,000. Gladwyn Financial Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth about $34,000. Finally, Piscataqua Savings Bank lifted its position in GE HealthCare Technologies by 173.4% in the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after purchasing an additional 300 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on GEHC shares. Citigroup upped their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Morgan Stanley boosted their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 30th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $89.83.

GE HealthCare Technologies Stock Down 2.6%

NASDAQ GEHC opened at $79.77 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a market capitalization of $36.34 billion, a P/E ratio of 16.48, a PEG ratio of 2.47 and a beta of 1.08. The company’s 50 day simple moving average is $81.98 and its 200 day simple moving average is $77.20. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter in the previous year, the business posted $1.14 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.